| Jul 31 |
British Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, Cuts Annual Vaccine Revenue Guidance
|
| Jul 31 |
ViiV Healthcare announces positive data demonstrating 2-drug regimen DOVATO is as effective as 3-drug regimen BIKTARVY for maintenance therapy of HIV-1
|
| Jul 31 |
GSK dips as vaccine headwinds overshadow guidance raise
|
| Jul 31 |
GSK (GSK) Tops Q2 Earnings and Revenue Estimates
|
| Jul 31 |
GSK reports Q2 results, updates FY guidance
|
| Jul 31 |
GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales
|
| Jul 31 |
Drugs firm GSK raises targets after strong cancer and HIV treatment sales
|
| Jul 30 |
GSK shingles vaccine cuts dementia risk
|
| Jul 30 |
GSK Q2 2024 Earnings Preview
|
| Jul 29 |
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
|
